Consumer Knowledge of Over-The-Counter Phenazopyridine

Published in: Annals of Family Medicine, v. 2, no. 3, May/June 2004, p. 240-244

Posted on RAND.org on January 01, 2004

by Chih-Wen Shi, Steven M. Asch, Eve Fielder, Lillian Gelberg, Michael B. Nichol

Read More

Access further information on this document at www.annfammed.org

This article was published outside of RAND. The full text of the article can be found at the link above.

BACKGROUND: Effective use of over-the-counter (OTC) medications depends on purchasers-- knowledge of their indications. This study examines consumer knowledge regarding the urinary tract analgesic phenazopyridine, which recently became available without prescription. METHOD: The authors conducted a cross-sectional survey of a stratified cluster random sample of purchasers of OTC phenazopyridine (N = 434) in 31 Los Angeles retail pharmacies. RESULTS: The response rate was 58%. Only 29% correctly characterized the likely cause of their symptoms, and only 57% correctly characterized the action of the drug. Worse consumer knowledge was associated with nonwhite race, first-time use, and less contact with health providers. CONCLUSION: Many consumers possess poor knowledge about phenazopyridine, potentially leading to undertreatment, especially in groups with worse access to care

This report is part of the RAND Corporation external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.